Health care stocks were mixed in Tuesday afternoon trading with the NYSE Health Care Index increasing 0.1% and the Health Care Select Sector SPDR Fund (XLV) little changed.
The iShares Biotechnology ETF (IBB) rose 0.6%.
In corporate news, Pfizer (PFE) shares gained 4.3%. The company projected higher earnings for 2025 and revenue in line with this year's likely results on "disciplined execution" and cost cuts.
Teva Pharmaceutical Industries (TEVA) shares surged 26% after the company's co-developed drug duvakitug was found to benefit people with inflammatory bowel disease. Teva's US affiliate and Sanofi (SNY) said a phase 2b study on duvakitug met primary endpoints in people with ulcerative colitis and Crohn's disease. Sanofi shares jumped 7.3%.
Vaccinex (VCNX) shares will be delisted from Nasdaq on Wednesday after the company failed to maintain a minimum of $2.5 million in stockholder equity. The stock plunged 62%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。